Expanding Epilepsy Treatment Options at Atlantic Health

At Atlantic Health, innovation in neurology is not just a goal; it’s a clinical reality. Nowhere is that more evident than in our work in neuromodulation for epilepsy, where world-class experts like Dr. Ron Benitez are pioneering less invasive, highly effective solutions that restore lives and change the trajectory of this chronic neurological disorder. With active programs at both Overlook Medical Center and Morristown Medical Center, we’re transforming how epilepsy is managed and redefining what’s possible in the broader field of neurology.

By
September 3, 2025
5 min

Atlantic Health System

Overview

Atlantic Health is advancing epilepsy treatment through innovative neuromodulation techniques, offering hope to patients with drug-resistant epilepsy. The program emphasizes early evaluation and a multidisciplinary approach to optimize patient outcomes.

Background

Epilepsy affects approximately 3 million Americans, with many patients experiencing inadequate seizure control despite medication. Traditional surgical options may not be suitable for all patients, highlighting the need for alternative treatments like neuromodulation. Atlantic Health's program aims to redefine epilepsy management through less invasive, effective solutions.

Data Highlights

No numerical data provided in the source material.

Key Findings

Minimally invasive neuromodulation options, such as RNS and LITT, are available for patients not suitable for traditional surgery.
Early evaluation for patients with persistent seizures is crucial to prevent entrenched seizure pathways.
Multidisciplinary case reviews and advanced imaging techniques enhance patient care and decision-making.
Collaboration with referring neurologists is emphasized to ensure comprehensive care throughout the treatment process.
Patients have reported significant improvements in quality of life, regaining control over daily activities.

Clinical Implications

Healthcare providers should consider early referral for patients with drug-resistant epilepsy to comprehensive centers like Atlantic Health. Utilizing neuromodulation techniques can provide new treatment avenues for patients who have exhausted traditional options.

Conclusion

Atlantic Health's innovative approach to epilepsy treatment through neuromodulation represents a significant advancement in managing this complex condition. The program's focus on early intervention and multidisciplinary care can lead to improved patient outcomes.